Shigeto Maeda
Omura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
CORRIGENDUM TO "EFFICACY AND SAFETY OF A DEXAMETHASONE-BASED MOUTHWASH TO PREVENT CHEMOTHERAPY-INDUCED STOMATITIS IN WOMEN WITH BREAST CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE 2 STUDY" [J EVID BASED DENT PRACT. 2023 SEP;23(3):101896].
Journal: The journal of evidence-based dental practice
Published: May 07, 2025
A retrospective multi-center cohort study investigating safety of sentinel lymph node biopsy for axillary staging in clinical T3-4c breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: March 27, 2025
Primary tumour resection plus systemic therapy versus systemic therapy alone in metastatic breast cancer (JCOG1017, PRIM-BC): a randomised clinical trial.
Journal: British journal of cancer
Published: March 06, 2025
A Resected Case of Metachronous Solitary Splenic Metastasis of Sigmoid Colon Cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: February 14, 2025
A randomized phase III study evaluating dexamethasone-based mouthwash to prevent chemotherapy-induced stomatitis in patients with breast cancer.
Journal: Japanese journal of clinical oncology
Published: August 05, 2024
Quality-Adjusted Survival in Patients with Recurrence of Breast Cancer Diagnosed by Asymptomatic or Symptomatic Opportunities.
Journal: The Kurume medical journal
Published: January 17, 2024
EFFICACY AND SAFETY OF A DEXAMETHASONE-BASED MOUTHWASH TO PREVENT CHEMOTHERAPY-INDUCED STOMATITIS IN WOMEN WITH BREAST CANCER: A MULTICENTRE, OPEN-LABEL, RANDOMISED PHASE 2 STUDY.
Journal: The journal of evidence-based dental practice
Published: December 14, 2022
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).
Journal: International journal of clinical oncology
Published: September 27, 2022
Last Updated: 09/26/2026